![Guo-Liang Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Guo-Liang Yu
Gründer bei
Innoforce Pharmaceuticals Co. Ltd.
Profil
Dr. Guo-Liang Yu is a Chairman at Zhejiang Crownmab Biotech Co. Ltd., a Chairman at Innoforce Pharmaceuticals Co. Ltd. and a Chairman at The BayHelix Group.
He is on the Board of Directors at Maijin Biomedical Technology (Shanghai) Co., Ltd., Immune-Onc Therapeutics, Inc., Alpine BioTherapeutics Corp., National Foundation for Cancer Research, The Chinese-American Biopharmaceutical Society, University of the Pacific and Zhejiang Innoforce Pharmaceuticals Co., Ltd. Dr. Yu was previously employed as an Independent Director by PlexBio Co., Ltd., a Chairman by Qyuns Therapeutics Co., Ltd., a Chairman & Chief Executive Officer by Apollomics, Inc. (United States), a Chairman & Chief Executive Officer by Apollomics, Inc., a Chairman & Chief Technology officer by Crown Bioscience International, an Executive Chairman & Chief Technology Officer by Crown Bioscience, Inc., a Co-Founder by QuanDx, Inc., a Chairman, President & Chief Executive Officer by Epitomics, Inc., a Senior Scientist by Human Genome Sciences, Inc., a Senior Vice President-Research & Development by Mendel Biotechnology, Inc., a Co-Founder by NVIGEN, Inc., a Venture Partner by OrbiMed Advisors Private Equity, and a President by The Chinese Biopharmaceutical Association.
He also served on the board at Ray Wu Memorial Fund and Applied StemCell, Inc. He received his undergraduate degree from Fudan University and a doctorate degree from the University of California, Berkeley.
Aktive Positionen von Guo-Liang Yu
| Unternehmen | Position | Beginn |
|---|---|---|
The BayHelix Group
 The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Vorsitzender | 01.01.2022 |
The Chinese-American Biopharmaceutical Society
 The Chinese-American Biopharmaceutical Society Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Direktor/Vorstandsmitglied | - |
National Foundation for Cancer Research
 National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research and development of cancer treatments | Direktor/Vorstandsmitglied | - |
University of the Pacific
 University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Gründer | 01.01.2016 |
Alpine BioTherapeutics Corp.
 Alpine BioTherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a technology that prevents and reverses the death of cells in the ocular cell system | Direktor/Vorstandsmitglied | - |
Zhejiang Crownmab Biotech Co. Ltd. | Vorsitzender | 29.05.2018 |
Maijin Biomedical Technology (Shanghai) Co., Ltd.
 Maijin Biomedical Technology (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs related to immunology | Direktor/Vorstandsmitglied | 01.03.2020 |
Innoforce Pharmaceuticals Co. Ltd.
 Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals | Gründer | 01.01.2018 |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Guo-Liang Yu
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Guo-Liang Yu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
27
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 27 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Health Technology |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization for drug discovery | Commercial Services |
Applied StemCell, Inc.
 Applied StemCell, Inc. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in cell and gene therapy development research | Health Technology |
NVIGEN, Inc.
 NVIGEN, Inc. Medical SpecialtiesHealth Technology Develops nanoparticle research reagents and devices for biomedical research applications | Health Technology |
QuanDx, Inc.
 QuanDx, Inc. Medical SpecialtiesHealth Technology Manufactures molecular diagnostic kits, assays and instruments | Health Technology |
Mendel Biotechnology, Inc.
 Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic and chemical solutions for the agricultural markets | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Pacific
University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
National Foundation for Cancer Research
National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research and development of cancer treatments | Commercial Services |
The BayHelix Group
The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Commercial Services |
The Chinese Biopharmaceutical Association | |
The Chinese-American Biopharmaceutical Society
The Chinese-American Biopharmaceutical Society Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Ray Wu Memorial Fund
 Ray Wu Memorial Fund The Ray Wu Memorial Fund honors Dr. Ray Wu, a life sciences scholar known for developing the first DNA sequencing method and advancing recombinant DNA technology. The private company is based in Birmingham, AL. The fund promotes scientific exchange and supports the CBEA program, which has enabled over 400 Chinese students to pursue Ph.D. studies. It annually awards the Ray Wu Prize to outstanding Ph.D. students in life sciences from mainland China, recognizing innovation, independent thinking, and dedication. The prize includes monetary awards, a medal, certificate, citation, travel support for conferences, and mentorship opportunities. The fund also acknowledges Prof. Gu Xiaocheng for her leadership in life sciences and her role in fostering scientific exchange and student support. | |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Operates as a biotechnology company that develops drug for oncology and metabolic diseases | Health Technology |
PlexBio Co., Ltd.
 PlexBio Co., Ltd. Medical SpecialtiesHealth Technology Engages in design, develop and manufacture of IVD product & instrument | Health Technology |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops targeted oncology drugs and immunotherapies | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Health Technology |
Qyuns Therapeutics Co., Ltd.
 Qyuns Therapeutics Co., Ltd. BiotechnologyHealth Technology Engages in research and development, manufacturing & sale of biologic therapies for autoimmune and allergic diseases | Health Technology |
Zhejiang Crownmab Biotech Co. Ltd. | |
Alpine BioTherapeutics Corp.
Alpine BioTherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a technology that prevents and reverses the death of cells in the ocular cell system | Commercial Services |
Maijin Biomedical Technology (Shanghai) Co., Ltd.
Maijin Biomedical Technology (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs related to immunology | Commercial Services |
Zhejiang Innoforce Pharmaceuticals Co., Ltd.
 Zhejiang Innoforce Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Innoforce Pharmaceuticals Co. Ltd.
Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals | Health Technology |
Apollomics, Inc.
 Apollomics, Inc. Financial ConglomeratesFinance Operates as a biotechnology company that focuses on development of novel medicines for cancer patients | Finance |
